Search
for
Sort by
Research 391–420 of 1000+
- Recent Progress in Prostaglandin F 2a Ethanolamide (Prostamide F2a) Research and Therapeutics
- Expanding the therapeutic landscape of sCD83 in hair disorders
- Drug Repurposing: Expanding Therapeutic Potential of Existing Drugs
- Drug Repurposing: Expanding Therapeutic Potential of Existing Drugs
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- Redox-directed interventions targeting skin photodamage
- Targeting the ovary in female patients with alopecia areata
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Identification of differentially expressed miRNAs in alopecia areata that target immune-regulatory pathways
- Chapter 23. Therapeutic Control of Androgen Action
- The antiviral activity of a small molecule drug targeting the NSP1-ribosome complex against Omicron, especially in elderly patients
- Exploring extracellular vesicles as novel therapeutic agents for intervertebral disc degeneration: delivery, applications, and mechanisms
- COVID-19: The question of genetic diversity and therapeutic intervention approaches
- Recent Insights in Multi‐Target Drugs in Pharmacology and Medicinal Chemistry
- Extracellular Vesicles in Skin: Biological Function and Therapeutic Potential
- Peptide-Based PROTACs: Transitioning from Static Paradigm to a Dynamic Landscape within Targeted Protein Degradation
- Melan-A Positive cells significantly expressed in immune-targeted follicles of Alopecia Areata
- Colon Cancer Stem Cells: Promise of Targeted Therapy
- Current and prospective strategies for advancing the targeted delivery of CRISPR/Cas system via extracellular vesicles
- N-(3,5-Dimethylphenyl)-3-Methoxybenzamide (A3B5) Targets TRP-2 and Inhibits Melanogenesis and Melanoma Growth
- Stem Cell-Derived Extracellular Vesicles: Promising Therapeutic Opportunities for Diabetic Wound Healing
- Protein kinase C is a key target for attenuation of Leigh syndrome by rapamycin
- Lupeol: an updated review utilizing AI-assisted predictive tools for enhanced therapeutic insights into lupeol’s potential for alopecia management
- Nano-Enabled CRISPR-Cas Gene Editing for Cancer Therapeutics
- <i>De novo</i> designed bifunctional proteins for targeted protein degradation
- Overcoming the Low Bioavailability of Apigenin: The Therapeutic Efficacy for Androgenetic Alopecia Through Topical Administration
- Quercetin Nanocrystal Gel: A Novel Topical Therapeutic Strategy for Androgenetic Alopecia
- 52243 AH-001: An Emerging Androgen Receptor Degrader Showing Therapeutic Potential in Addressing Androgenetic Alopecia (AGA)
- Poria cocos polysaccharides attenuate chronic nonbacterial prostatitis by targeting the gut microbiota: Comparative study of Poria cocos polysaccharides and finasteride in treating chronic prostatitis
- Bio-inspired suction cup microneedle loaded fusion membrane targeting nano-drug delivery system treat androgenetic alopecia